Evidence map›Paper›PMID 41145883›Full record

ArticleNPJ digital medicine2025

Benchmarking large language models for personalized, biomarker-based health intervention recommendations.

Hans Jarchow, Christoph Bobrowski, Steffi Falk, Andreas Hermann, Anton Kulaga, Johann-Christian Põder, Maximilian Unfried, Nikolay Usanov, Bijan Zendeh, Brian K Kennedy and 2 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hans JarchowInstitute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany.
Christoph BobrowskiKlinik für Neurologie und Geriatrie, Johanniter-Krankenhaus Stendal, Stendal, Germany.
Steffi FalkKlinik für Unfall-, Hand- und Wiederherstellungschirurgie, Rostock University Medical Center, Rostock, Germany.
Andreas HermannTranslational Neurodegeneration Section "Albrecht Kossel", and Rostock University Medical Center, Rostock, Germany.
Anton KulagaInstitute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany.
Johann-Christian PõderEthics in Theology and Medicine, Faculty of Theology, Rostock University Faculty of Theology, Rostock, Germany.
Maximilian UnfriedHealthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Nikolay UsanovHEAlthy Life Extension Society (HEALES), Brussels, Belgium.
Bijan ZendehDept. of Neurology, Rostock University Medical Center, Rostock, Germany.
Brian K KennedyHealthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. bkennedy@nus.edu.sg.
Sebastian LobentanzerInstitute of Computational Biology, Computational Health Center, Helmholtz Center, Munich, Germany. sebastian.lobentanzer@helmholtz-munich.de.
Georg FuellenInstitute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany. fuellen@alum.mit.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of large language models (LLMs) in clinical diagnostics and intervention planning is expanding, yet their utility for personalized recommendations for longevity interventions remains opaque. We extended the BioChatter framework to benchmark LLMs' ability to generate personalized longevity intervention recommendations based on biomarker profiles while adhering to key medical validation requirements. Using 25 individual profiles across three different age groups, we generated 1000 diverse test cases covering interventions such as caloric restriction, fasting and supplements. Evaluating 56000 model responses via an LLM-as-a-Judge system with clinician validated ground truths, we found that proprietary models outperformed open-source models especially in comprehensiveness. However, even with Retrieval-Augmented Generation (RAG), all models exhibited limitations in addressing key medical validation requirements, prompt stability, and handling age-related biases. Our findings highlight limited suitability of LLMs for unsupervised longevity intervention recommendations. Our open-source framework offers a foundation for advancing AI benchmarking in various medical contexts.

Identifiers

PMID41145883
PMCPMC12559286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.